Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
An Open-Label Phase 1/2 Study Evaluating the Safety and Efficacy of Etentamig (ABBV-383) in AL Amyloidosis
Immunoglobulin light chain (AL) amyloidosis is the most common form of systemic amyloidosis. AL amyloidosis has many root causes and is characterized by the ov…
Immunoglobulin Light Chain (AL) Amyloidosis
AbbVieNCT06158854
Phase 1
Phase 1b/2 Study of NXC-201 for the Treatment of Patients With Relapsed or Refractory AL Amyloidosis
Open-label Phase 1b Dose Escalation/Dose Expansion study exploring the safety and efficacy of NXC-201 in patients with relapsed or refractory light chain amylo…
Light Chain (AL) Amyloidosis
Nexcella Inc.NCT06097832